TORONTO, Jun 08, 2005 (United Press International via COMTEX) -- Toronto researcher Andras Nagy has developed and won approval of Canada's first two lines of embryonic stem cells, the University of Toronto said Wednesday.
"My hope -- and the hope of my world-class laboratory team -- is that our step of developing the first Canadian embryonic stem cell lines will ultimately bring Canada and the world closer to treating or curing diseases such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, diabetes and spinal cord injuries," said Nagy.
Nagy is a professor at the University of Toronto and a researcher at Mount Sinai Hospital in Toronto.
Canada's Stem Cell Network will oversee the two stem cell lines, which Scientific Director Michael Rudnicki said will be shared with researchers around the world.
"Having our own cell lines gives Canadian researchers access to a valuable research tool," Rudnicki said.